Physician profile
April Graham
NPI 1144588674
$379.56
in general payments reported to CMS, 2019-2025
14 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $22.57 · 2021: $12.58 · 2022: $44.83 · 2023: $47.61 · 2024: $33.14 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $42.08 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $39.31 | 2019-2023 | Gardasil 9 |
| Kaleo, INC. | $38.29 | 2019-2020 | |
| Viiv Healthcare Company | $34.95 | 2025 | Apretude |
| Pfizer INC. | $33.83 | 2024-2025 | |
| Corium, LLC | $32.91 | 2022-2023 | Azstarys |
| Glaxosmithkline, LLC. | $30.19 | 2019-2025 | Nucala |
| Phadia US INC. | $27.75 | 2020-2023 | Immunocap |
| Abbott Laboratories | $23.16 | 2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $19.90 | 2025 | Zepbound, Mounjaro |
| Alk-Abello, INC | $16.88 | 2024 | Ragwitek, Odactra, Grastek |
| Cranial Technologies, INC | $14.98 | 2019 | |
| Hologic Sales and Service, LLC | $14.54 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.